Anti-atherosclerotic therapies: milestones, challenges, and emerging innovations

I Hetherington, H Totary-Jain - Molecular Therapy, 2022 - cell.com
Atherosclerosis is the main underlying pathology for many cardiovascular diseases (CVDs),
which are the leading cause of death globally and represent a serious health crisis …

Deranged myocardial fatty acid metabolism in heart failure

T Yamamoto, M Sano - International journal of molecular sciences, 2022 - mdpi.com
The heart requires fatty acids to maintain its activity. Various mechanisms regulate
myocardial fatty acid metabolism, such as energy production using fatty acids as fuel, for …

Statins and inflammation: new therapeutic opportunities in psychiatry

SW Kim, HJ Kang, M Jhon, JW Kim, JY Lee… - Frontiers in …, 2019 - frontiersin.org
Statins, which are widely used to treat hypercholesterolemia, have anti-inflammatory and
anti-oxidant effects. These are thought to be responsible for the potential effects of statins on …

Effect of hypercholesterolaemia on myocardial function, ischaemia–reperfusion injury and cardioprotection by preconditioning, postconditioning and remote …

I Andreadou, EK Iliodromitis, A Lazou… - British journal of …, 2017 - Wiley Online Library
Hypercholesterolaemia is considered to be a principle risk factor for cardiovascular disease,
having direct negative effects on the myocardium itself, in addition to the development of …

Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases

C Ulivieri, CT Baldari - Pharmacological Research, 2014 - Elsevier
Statins, a class of drugs that act as inhibitors of cholesterol biosynthesis and protein
isoprenylation, have been proposed as immunomodulatory agents due to their potent effects …

Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?

P Balakumar, S Kathuria, G Taneja, S Kalra… - Journal of molecular and …, 2012 - Elsevier
Statins are widely used in the treatment of dyslipidemia and associated cardiovascular
abnormalities including atherosclerosis, hypertension and coronary heart disease. Needless …

[HTML][HTML] Protective effects of atorvastatin and quercetin on isoprenaline-induced myocardial infarction in rats

MA Zaafan, HF Zaki, AI El-Brairy, SA Kenawy - Bulletin of Faculty of …, 2013 - Elsevier
Myocardial infarction (MI) continues to be a major public health problem in the world. Statins
exhibit cardio-protective effects by several mechanisms beyond their lipid lowering activity …

Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway

NM Al-Rasheed, MM Al-Oteibi… - Drug Design …, 2015 - Taylor & Francis
Simvastatin (SIM) is a lipid-soluble inhibitor of hydroxy-3-methylglutaryl coenzyme A
reductase with multiple reported therapeutic benefits. The present study was designed to …

A step ahead of PPARγ full agonists to PPARγ partial agonists: therapeutic perspectives in the management of diabetic insulin resistance

S Chigurupati, SA Dhanaraj, P Balakumar - European journal of …, 2015 - Elsevier
Described since long as a member of the nuclear receptor superfamily, peroxisome
proliferator-activated receptors (PPARs) regulate the gene expression of proteins involved in …

[HTML][HTML] Atorvastatin protects myocardium against ischemia-reperfusion injury through inhibiting miR-199a-5p

YB Zuo, YZ Wang, HJ Hu, W Cui - Cellular Physiology and Biochemistry, 2016 - karger.com
Objective: This study aimed to evaluate the protective effects of atorvastatin against
myocardial ischemia/reperfusion (I/R) injury in cardiomyocytes and its possible underlying …